Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
A mixture of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane; 1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane; spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan]; spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan]
EC number: 422-040-1 | CAS number: 426218-78-2 CASSIFFIX
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The substance is negative in the Ames test (OECD TG 471).
The substance is negative in the Chromosome Aberration test (OECD TG 473).
The substance is negative in the Mouse Lymphoma Assay (OECD TG 490).
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
The bacterial reverse mutation (Ames) study
The substance is tested in the Ames test (OECD TG 471), using Salmonella typhimurium strains TA100, TA1535, TA98 and TA1537 and E. coli strain WP2uvrA. In the range finding test (plate incorporation), the substance was tested up to a concentration of 5000 µg/plate. The substance was toxic towards all tester strains in both 5000 µg/plate and 500 µg/plate. In the main test, the substance was tested up to a concentration of 500 µg/plate in two mutation experiments (plate incorporation). In the first experiment, toxicity was observed in all tester strains at a concentration of500µg/plate. In strains TA100 and TA1538, toxic responses were also observed at 125µg/plate. No growth in bacterial background lawns and/or substantial decreases in revertant colony frequency were recorded for any of the bacterial strains, with any dose of the test substance, either with or without metabolic activation. Based on this, the substance is not mutagenic in the Ames test.
In vitro cytogenicity
The substance is tested in the Mammalian Chromosome Aberration test (OECD TG 473). The substance was evaluated for chromosome aberrations in two experiments and an additional confirmatory test. In the first experiment, the substance was tested in absence of S9 -mix for 18 and 32 hours and in the presence of S9 -mix for 3 hours with 15 and 29 hours of fixation time at concentrations up to 500 μg/mL. In the second experiment the substance was tested in the presence of S9 -mix for an exposure time of 3 hours with 15 and 29 hours fixation time at concentrations up to 500 μg/mL. An additional confirmatory test was performed in absence of S9 -mix with a harvest time of 18 hours and concentrations up to 75 μg/mL. Cytotoxicity was observed in all treatments and based on these data, the concentrations for metaphase analysis were determined. No treatment related increases in aberrant cells were observed, neither did the substance induce an increase in the numbers of polyploid cells, either in the absence or presence of metabolic activation. Both positive control compounds, ethyl methanesulphonate and cyclophosphamide, caused large statistically significant increases in the proportion of aberrant cells showing the sensitivity of the test system. Based on this, the substance is not cytogenic in the Mammalian Chromosome Aberration test.
Mouse lymphoma assay test
The substance is tested in the Mouse Lymphoma Assay (OECD TG 490). Mouse lymphoma L5178Y cells cultured in vitro were exposed to the substance in duplicate, both with and without metabolic activation (S9 -mix). The substance was tested in eight dose levels in the first experiment: 1 to 40 µg/mL for the 4-hour –S9 exposure and 3 to 200 µg/mL in the 4-hour +S9 exposure and in the second experiment: 3 to 45 µg/mL for the 24-hour –S9 exposure and 10 to 350μg/mL for the 3 -hour +S9 exposure. The substance was tested beyond the limit of the solubility. In both experiments no significant increase in the mutation frequency at the TK locus was observed after treatment with the substance either in the absence or in the presence of S9-mix. The numbers of small and large colonies in the test substance treated cultures were comparable to the numbers of small and large colonies of the solvent controls. Based on this, the substance is not mutagenic in the Mouse Lymphoma Assay.
Justification for classification or non-classification
Based on the results of the genemutations in bacterial cells (Ames test), cytogenicity information (Chromosome Aberration test) and the genemutations in mammalian cells (Mouse Lymphoma Assay), the substance is not genotoxic and therefore does not have to be classified for genotoxicity in accordance with EU CLP (EC no. 1272/2008 and its amendments).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.